Stepan Sees 2026 Project Catalyst Savings Of $66 Million To $70 Million, Above Its $60 Million Target

The chemicals maker's CEO said savings should keep climbing in 2027 as its Pasadena plant ramps from 75% to 80% utilization.

Share
Stepan Sees 2026 Project Catalyst Savings Of $66 Million To $70 Million, Above Its $60 Million Target

Stepan's cost-cutting program is running ahead of plan: CEO Luis Rojo told analysts on the company's third-quarter earnings call that 2026 Project Catalyst savings should land in a $66 million to $70 million range, against a $60 million target. Stepan, which makes specialty and intermediate chemicals for other manufacturers, also said savings should keep rising through 2027.

Savings run rate heads above $25 million

Asked by an analyst from Seaport Research Partners whether the $40 million of incremental savings expected next year was still the right number, Rojo said the company is delivering a run rate of about $23 million a quarter. He said management has identified actions that should let it beat $25 million a quarter on average in 2027, or $2 million to $3 million more than today.

The ramp will be weighted to the back half, Rojo said: slightly below $25 million in the first half and above it in the second, as production rises at the Pasadena, Texas plant and other projects come through. Chief Financial Officer Ruben Velasquez said the program's two-year pre-tax target is $100 million and that Stepan expects to exceed the 2026 portion.

Rojo cautioned that these savings sit against ordinary inflation on a fixed cost base of roughly $800 million, which he said to model at 2% to 3%.

Pasadena at 75% to 80% of capacity

Answering a Singular Research analyst, Rojo said Pasadena is running at 75% to 80% utilization. He said the team is focused on maximizing dollar return rather than volume, because products differ in how long they tie up a reactor, and that the plant is delivering more tolling savings than expected in 2026.

A quarter of earnings growth

Stepan reported third-quarter adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) of $66.3 million, up 18% from a year earlier. Adjusted earnings were $0.94 a share, up from $0.48, and organic volume grew 7%, with gains in all three segments: surfactants, polymers and specialty products.

Reported net income was $17.8 million, or $0.78 a share, including a $5.6 million pre-tax restructuring charge. Free cash flow was $8 million, and net debt ended the quarter at $536 million, a leverage ratio of 2.4 times, down from 2.7 times a year earlier.

In October, Stepan closed the sale of a land parcel near its Millsdale site for $28.5 million, and Rojo said all the proceeds will go to pay down debt. The company also raised its quarterly dividend by a penny a share, or 2.5%, which Rojo called the 59th consecutive year of increases.

Rojo said the company expects full-year adjusted EBITDA growth, positive free cash flow and further debt reduction in 2026.

Sources

More on Stepan

All Stepan (SCL) coverage →